PL4349334T3 - Smaczny ciekły roztwór zawierający wysokie stężenie miglustatu - Google Patents
Smaczny ciekły roztwór zawierający wysokie stężenie miglustatuInfo
- Publication number
- PL4349334T3 PL4349334T3 PL22306512.9T PL22306512T PL4349334T3 PL 4349334 T3 PL4349334 T3 PL 4349334T3 PL 22306512 T PL22306512 T PL 22306512T PL 4349334 T3 PL4349334 T3 PL 4349334T3
- Authority
- PL
- Poland
- Prior art keywords
- miglustat
- solution containing
- high concentration
- liquid solution
- containing high
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Seasonings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22306512.9A EP4349334B1 (en) | 2022-10-07 | 2022-10-07 | Palatable liquid solution containing high concentration of miglustat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4349334T3 true PL4349334T3 (pl) | 2025-07-14 |
Family
ID=83903187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22306512.9T PL4349334T3 (pl) | 2022-10-07 | 2022-10-07 | Smaczny ciekły roztwór zawierający wysokie stężenie miglustatu |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP4349334B1 (pl) |
| CN (1) | CN120390639A (pl) |
| AU (1) | AU2023357503A1 (pl) |
| CL (1) | CL2025001013A1 (pl) |
| CO (1) | CO2025005057A2 (pl) |
| CR (1) | CR20250179A (pl) |
| DO (1) | DOP2025000082A (pl) |
| ES (1) | ES3031740T3 (pl) |
| HR (1) | HRP20250679T1 (pl) |
| HU (1) | HUE071860T2 (pl) |
| MX (1) | MX2025004114A (pl) |
| PE (1) | PE20251532A1 (pl) |
| PL (1) | PL4349334T3 (pl) |
| SM (1) | SMT202500225T1 (pl) |
| WO (1) | WO2024074723A1 (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0614947D0 (en) * | 2006-07-27 | 2006-09-06 | Isis Innovation | Epitope reduction therapy |
| ES2779006T3 (es) | 2013-01-09 | 2020-08-13 | Amicus Therapeutics Inc | Composiciones de DNJ parenterales estables |
| EP3944858A1 (en) * | 2020-07-30 | 2022-02-02 | Beyond Batten Disease Foundation | Combination product containing trehalose and miglustat for treating lysosomal diseases |
-
2022
- 2022-10-07 PL PL22306512.9T patent/PL4349334T3/pl unknown
- 2022-10-07 SM SM20250225T patent/SMT202500225T1/it unknown
- 2022-10-07 HR HRP20250679TT patent/HRP20250679T1/hr unknown
- 2022-10-07 HU HUE22306512A patent/HUE071860T2/hu unknown
- 2022-10-07 EP EP22306512.9A patent/EP4349334B1/en active Active
- 2022-10-07 ES ES22306512T patent/ES3031740T3/es active Active
-
2023
- 2023-10-09 AU AU2023357503A patent/AU2023357503A1/en active Pending
- 2023-10-09 PE PE2025000761A patent/PE20251532A1/es unknown
- 2023-10-09 CN CN202380084161.0A patent/CN120390639A/zh active Pending
- 2023-10-09 EP EP23787089.4A patent/EP4598529A1/en active Pending
- 2023-10-09 CR CR20250179A patent/CR20250179A/es unknown
- 2023-10-09 WO PCT/EP2023/077910 patent/WO2024074723A1/en not_active Ceased
-
2025
- 2025-04-02 DO DO2025000082A patent/DOP2025000082A/es unknown
- 2025-04-03 CL CL2025001013A patent/CL2025001013A1/es unknown
- 2025-04-04 MX MX2025004114A patent/MX2025004114A/es unknown
- 2025-04-23 CO CONC2025/0005057A patent/CO2025005057A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20251532A1 (es) | 2025-06-05 |
| EP4598529A1 (en) | 2025-08-13 |
| EP4349334A1 (en) | 2024-04-10 |
| SMT202500225T1 (it) | 2025-07-22 |
| WO2024074723A1 (en) | 2024-04-11 |
| AU2023357503A1 (en) | 2025-04-24 |
| CN120390639A (zh) | 2025-07-29 |
| HUE071860T2 (hu) | 2025-09-28 |
| DOP2025000082A (es) | 2025-07-31 |
| ES3031740T3 (en) | 2025-07-10 |
| CR20250179A (es) | 2025-09-04 |
| MX2025004114A (es) | 2025-09-02 |
| CL2025001013A1 (es) | 2025-08-08 |
| EP4349334B1 (en) | 2025-03-19 |
| EP4349334C0 (en) | 2025-03-19 |
| CO2025005057A2 (es) | 2025-07-28 |
| HRP20250679T1 (hr) | 2025-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Takai et al. | Molecular mechanism of plasma sterilization in solution with the reduced pH method: importance of permeation of HOO radicals into the cell membrane | |
| AR076466A1 (es) | Sistema y proceso de potabilizacion de agua, a traves del medio ambiente y/o de agua obtenida de red municipal o colectiva, y/o de agua obtenida de pozo, y/o de agua obtenida en recipientes domesticos e industriales | |
| PL4349334T3 (pl) | Smaczny ciekły roztwór zawierający wysokie stężenie miglustatu | |
| IL188402A0 (en) | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate | |
| PH12019550022A1 (en) | Anti-ageing pharmaceutical preparation | |
| CA3269189A1 (en) | Palatable liquid solution containing high concentration of miglustat | |
| GB202110420D0 (en) | Liquid pharmaceutical composition of clonidine | |
| IL314790A (en) | Sterilization process of a sterile liquid pharmacy preparation containing ansiphantrine | |
| WO2016171483A1 (ko) | 수소수 생산 장치 | |
| TW200506003A (en) | Aqueous shellac coating agent and production process therefor, and coated food and production process therefor, coated drug and production process therefor, glazing composition for oil-based confectionary, glazing process, and confectionary using same | |
| LT2015087A (lt) | Saugus ir naudingas geriamasis vanduo ir jo paruošimo būdas | |
| EP4463701A4 (en) | Liquid biopsy analysis of cell states to predict immunotherapy toxicity | |
| IL272680A (en) | Treatment of flowing streams containing high concentrations of solids using an absorbent purifier | |
| RU2012154914A (ru) | Улучшенный способ получения нацеленного на фолат средства | |
| UA43607U (ru) | Способ производства консервов "фруктейль вишневый" | |
| EP3995586A4 (en) | GLYCOSYLATED PROTEIN TEST REAGENT WITH PROTEAS STABILIZER TO INCREASE THE REDOX POTENTIAL OF FERROCYANIDE, METHODS FOR ANALYZING GLYCOSYLATED PROTEIN, METHODS FOR PRESERVING A GLYCOSYLATED PROTEIN TEST REAGENT, AND METHODS FOR STABILIZING A GLYCOSYLATED PROTEIN TEST REAGENT | |
| HK40114702A (en) | Methods of preparing high concentration liquid drug substances | |
| IT202200002585A1 (it) | Processo per il trattamento di acque contenenti ammoniaca | |
| DK4125399T3 (da) | Sammensætning til fermenterede eller syrnede mælkeprodukter, dens anvendelse, produkter, der indeholder denne, og fremgangsmåde til fremstilling af disse produkter | |
| PL419199A1 (pl) | 1'-(3,7,11,15-Tetrametylo-3-winyloheksadecylo)-2'-hydroksy-sn-glicero-3'-fosfatydylocholina i sposób jej otrzymywania | |
| BR112016028768A2 (pt) | sistema e método para processamento de um produto alimentício líquido ou semilíquido, e, produto alimentício líquido ou semilíquido. | |
| CA3271489A1 (en) | Pharmaceutical composition containing high concentration of opiranserin | |
| GB202418561D0 (en) | Delivery of molecules into biological cells | |
| IL314788A (en) | Modified release valproic acid softgel capsule | |
| CA233184S (en) | Liquid container |